Early antiretroviral treatment in people with HIV infection could allow the generation of more functional and persistent CD8 T cell responses. The results, which suggest a long-term immune memory, could have implications for HIV vaccine development.
Healthcare practitioners have split opinions on whether primary care doctors or other providers should take the lead on prescribing PrEP for HIV prevention, according to new research.
New research describes the use of small-molecule CD4 mimetic compounds that force HIV to undergo conformational changes, exposing normally hidden parts of the envelope and potential new targets.
A second individual has achieved sustained remission from HIV-1 after ceasing antiretroviral treatment, according to researchers from University College London. Following a hematopoietic stem cell transplant and chemotherapy the patient has had undetectable viral loads for 18 months.
New research has developed a nanoparticle formulation that can knock down a key chlamydia binding protein and simultaneously induce autophagy – showing promise against this infection.
Take a look behind the scenes of a recent Future Virology paper as we ask author Darrell Tan about the potential of pre-exposure prophylaxis (PrEP) for HIV prevention, PrEP failure and what research is needed in the field.
State media has reported that the number of people living with HIV/AIDS has increased by 14% year-on-year.
The European Gonococcal Antimicrobial Surveillance Programme has revealed high levels of azithromycin resistance in Europe, however, these have remained relatively stable.
Primarily transferred via direct contact with the blood or bodily fluids of infected people, the Ebola virus receives a significant boost to its infective properties from amyloid fibrils in human semen, according to a new study.
Data from Public Health England has reported a 20% rise in cases of syphilis and a 22% rise in gonorrhoea, a concern with the emergence of multi-drug resistance.
